| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 6834 |
| 1 | PREDNISONE | 2125 |
| 2 | VEDOLIZUMAB | 1413 |
| 3 | INFLIXIMAB | 1408 |
| 4 | ERGOCALCIFEROL | 1375 |
| 5 | OMEPRAZOLE MAGNESIUM | 1310 |
| 6 | ORAL SEMAGLUTIDE | 1310 |
| 7 | RISANKIZUMAB-RZAA | 1256 |
| 8 | ACETAMINOPHEN | 1249 |
| 9 | PANTOPRAZOLE | 1153 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 452 | 0.1312 |
| 1 | PSYLLIUM HUSK | 85 | 0.0629 |
| 2 | ERGOCALCIFEROL | 1375 | 0.0462 |
| 3 | TEDUGLUTIDE | 419 | 0.0312 |
| 4 | ADALIMUMAB-AFZB | 60 | 0.0224 |
| 5 | LOXAPINE | 87 | 0.0218 |
| 6 | TRIHEXYPHENIDYL HYDROCHLORIDE | 21 | 0.0206 |
| 7 | OCTREOTIDE ACETATE | 592 | 0.0193 |
| 8 | COLESTIPOL HYDROCHLORIDE | 50 | 0.0188 |
| 9 | MESALAMINE | 524 | 0.0186 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3759 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 2586 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2546 |
| 3 | GLP-1 Receptor Agonist [EPC] | 2081 |
| 4 | Benzodiazepine [EPC] | 1933 |
| 5 | Interleukin-23 Antagonist [EPC] | 1925 |
| 6 | Proton Pump Inhibitor [EPC] | 1751 |
| 7 | Integrin Receptor Antagonist [EPC] | 1603 |
| 8 | Atypical Antipsychotic [EPC] | 1562 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 1445 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 202 | 0.0973 |
| 1 | Interleukin-5 Antagonist [EPC] | 57 | 0.0828 |
| 2 | Provitamin D2 Compound [EPC] | 1375 | 0.0462 |
| 3 | GLP-2 Analog [EPC] | 419 | 0.0312 |
| 4 | Integrin Receptor Antagonist [EPC] | 1603 | 0.0184 |
| 5 | Interleukin-23 Antagonist [EPC] | 1925 | 0.0184 |
| 6 | Serotonin-4 Receptor Agonist [EPC] | 11 | 0.0167 |
| 7 | Lysosomal beta Glucuronidase [EPC] | 1 | 0.0156 |
| 8 | Human Blood Coagulation Factor [EPC] | 12 | 0.0146 |
| 9 | Bile Acid Sequestrant [EPC] | 167 | 0.0137 |